Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.
Noll A; Myers C; Biery MC; Meechan M; Tahiri S; Rajendran A; Berens ME; Paine D; Byron S; Zhang J; Winter C; Pakiam F; Leary SES; Cole BL; Jackson ER; Dun MD; Foster JB; Evans MK; Pattwell SS; Olson JM; Vitanza NA.
Neoplasia
(Unknown)
Published: 2023
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors.
Di Fiore A; Bellardinelli S; Pirone L; Russo R; Angrisani A; Terriaca G; Bowen M; Bordin F; Besharat ZM; Canettieri G; Fabretti F; Di Gaetano S; Di Marcotullio L; Pedone E; Moretti M; De Smaele E.
Neoplasia
(Unknown)
Published: 2023
Altered endosomal-lysosomal biogenesis in melanoma.
Lam GT; Sorvina A; Martini C; Prabhakaran S; Ung BS; Lazniewska J; Moore CR; Beck AR; Hopkins AM; Johnson IRD; Caruso MC; Hickey SM; Brooks RD; Jackett L; Karageorgos L; Foster-Smith EJ; Malone V; Klebe S; O'Leary JJ; Brooks DA; Logan JM.
Neoplasia
(Unknown)
Published: 2023
Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells.
Carreira ASA; Ravera S; Zucal C; Thongon N; Caffa I; Astigiano C; Bertola N; Buongiorno A; Roccuzzo M; Bisio A; Pardini B; Nencioni A; Bruzzone S; Provenzani A.
Neoplasia
(Unknown)
Published: 2023
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and …
Fitzel R; Secker-Grob KA; Keppeler H; Korkmaz F; Schairer R; Erkner E; Schneidawind D; Lengerke C; Hentrich T; Schulze-Hentrich JM; Schneidawind C.
Neoplasia
(Unknown)
Published: 2023